Related Experiment Video
Updated: Dec 10, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Cancer risk in Korean patients with gout
Yoon-Jeong Oh1, Yun Jong Lee2, Eunyoung Lee3,4
1Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.
Background/Aims:
Using a nationwide cohort, we investigated the cancer risk in Korean patients with gout.
Methods:
Data were obtained from the Korean National Health Insurance Service Database. Patients with gout were defined as those aged ≥ 20 years who were diagnosed with gout and received anti-gout medication (allopurinol, colchicine, and benzbromarone) between 2008 and 2010. Patients with nail disorders were randomly assigned to a control group (1:1 ratio) after frequency matching for age and sex. Cancer incidence was then investigated between 2012 and 2018. Cox proportional hazard regression analysis was used to investigate the association between gout and cancer after adjusting for concomitant diseases.
Results:
This study included 179,930 patients with gout and an equal number of matched controls. The incidence of overall cancer was higher in patients with gout than in controls (incidence rate ratio, 1.08). Cox proportional hazards regression analysis showed that gout was associated with a hazard ratio of 1.053 (95% confidence interval ,1.031 to 1.077) after adjusting for concomitant diseases.
Conclusion:
Gout was associated with a significantly high risk of cancer, especially esophageal, stomach, colon, liver, pancreatic, lung, ovarian, renal, and bladder cancers.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
10:31Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma
Published on: August 9, 2016
Related Concept Videos
Cancer Prevention
Some...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Chronic Kidney Disease II: Clinical Manifestations
Targeted Cancer Therapies
There are several types of targeted therapies against...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Cancer Survival Analysis